Strategic asset sale Vyaire Medical has divested its RDx respiratory diagnostics unit to Trudell Medical, rebranding as Jaeger. This presents a near-term opportunity to engage Jaeger (formerly Vyaire RDx) for ongoing hardware, consumables, and services across pulmonary function and cardio-pulmonary testing markets.

Bankruptcy clearance The company filed for Chapter 11 and is focused on selling assets to stable buyers. Targeted outreach to potential buyers and partners who acquired or can acquire Vyaire units may uncover integration opportunities for complementary products and services.

Ventilator asset auction Auction results indicate winning bidders for the ventilator business; opportunities may exist to offer replacement parts, service contracts, training, and remote monitoring solutions to the newly independent ventilator business unit.

R&D and testing focus Jaeger continues active worldwide in pulmonary function testing and cardio-pulmonary exercise testing; there is potential to upsell new diagnostic hardware, consumables, and support services to existing Jaeger customers and clinics expanding their PFT capabilities.

Revenue potential With prior revenue in the mid tens of millions and a broad global footprint, there is room to pursue cross-sell of airway management and respiratory care consumables, targeting hospitals, clinics, and research centers that previously used Vyaire or competing brands.